Falsely decreased thyroglobulin levels in a patient with differentiated thyroid carcinoma.

Hillebrand, J J; Siegelaar, S E; Heijboer, A C

Hillebrand, J J; Siegelaar, S E; Heijboer, A C.

Afiliação

Hillebrand JJ; Amsterdam UMC, University of Amsterdam, Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam, the Netherlands. Electronic address: j.j.hillebrand@amsterdamumc.nl.
Siegelaar SE; Amsterdam UMC, University of Amsterdam, Department of Endocrinology & Metabolism, Amsterdam, the Netherlands.
Heijboer AC; Amsterdam UMC, University of Amsterdam, Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam, the Netherlands; Amsterdam UMC, Vrije Universiteit Amsterdam, Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam Gastroenterology & Metabolism, Amsterdam, the Netherlands.

Clin Chim Acta ; 509: 217-219, 2020 Oct.

Article em En | MEDLINE | ID: mdl-32561346

Assuntos

Tireoglobulina; Neoplasias da Glândula Tireoide; Seguimentos; Humanos; Radioisótopos do Iodo/uso terapêutico; Neoplasias da Glândula Tireoide/diagnóstico; Neoplasias da Glândula Tireoide/cirurgia; Tireoidectomia

Palavras-chave

High dose hook; Interference; Prozone effect; Tg; Thyroid carcinoma; Tumor marker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tireoglobulina / Neoplasias da Glândula Tireoide Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google